rdf:type |
|
lifeskim:mentions |
umls-concept:C0017661,
umls-concept:C0024501,
umls-concept:C0025815,
umls-concept:C0034107,
umls-concept:C0038317,
umls-concept:C0040423,
umls-concept:C0087111,
umls-concept:C0128608,
umls-concept:C0205195,
umls-concept:C0205210,
umls-concept:C0232804,
umls-concept:C0544452,
umls-concept:C1280500,
umls-concept:C1521828
|
pubmed:issue |
1
|
pubmed:dateCreated |
2011-2-17
|
pubmed:abstractText |
The long-term prognosis of immunoglobulin A nephropathy (IgAN) is reportedly poor. In Japan, tonsillectomy-steroid pulse therapy has frequently been used for treatment of early IgAN, with favorable outcomes. However, steroid usage is sometimes limited due to adverse reactions. To reduce the total dose of steroids, we have been using mizoribine (MZR) in combination with tonsillectomy-steroid pulse therapy since 2004. Here we report a retrospective evaluation of our protocol outcome.
|
pubmed:commentsCorrections |
http://linkedlifedata.com/resource/pubmed/commentcorrection/20972695-10574997,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20972695-10903900,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20972695-11231363,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20972695-11549900,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20972695-11576876,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20972695-14586726,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20972695-14694168,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20972695-14726626,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20972695-15550753,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20972695-17699253,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20972695-18508946,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20972695-19339088,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20972695-2007290,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20972695-4180586,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20972695-8325022,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20972695-9366383,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20972695-9609465
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Feb
|
pubmed:issn |
1437-7799
|
pubmed:author |
|
pubmed:issnType |
Electronic
|
pubmed:volume |
15
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
73-8
|
pubmed:dateRevised |
2011-7-27
|
pubmed:meshHeading |
pubmed-meshheading:20972695-Adolescent,
pubmed-meshheading:20972695-Adult,
pubmed-meshheading:20972695-Female,
pubmed-meshheading:20972695-Glomerular Filtration Rate,
pubmed-meshheading:20972695-Glomerulonephritis, IGA,
pubmed-meshheading:20972695-Glucocorticoids,
pubmed-meshheading:20972695-Humans,
pubmed-meshheading:20972695-Immunosuppressive Agents,
pubmed-meshheading:20972695-Japan,
pubmed-meshheading:20972695-Kidney,
pubmed-meshheading:20972695-Kidney Failure, Chronic,
pubmed-meshheading:20972695-Kidney Function Tests,
pubmed-meshheading:20972695-Male,
pubmed-meshheading:20972695-Methylprednisolone,
pubmed-meshheading:20972695-Middle Aged,
pubmed-meshheading:20972695-Pulse Therapy, Drug,
pubmed-meshheading:20972695-Remission Induction,
pubmed-meshheading:20972695-Retrospective Studies,
pubmed-meshheading:20972695-Ribonucleosides,
pubmed-meshheading:20972695-Tonsillectomy,
pubmed-meshheading:20972695-Treatment Outcome,
pubmed-meshheading:20972695-Young Adult
|
pubmed:year |
2011
|
pubmed:articleTitle |
Methylprednisolone pulse therapy combined with mizoribine following tonsillectomy for immunoglobulin A nephropathy: clinical remission rate, steroid sparing effect, and maintenance of renal function.
|
pubmed:affiliation |
Division of Neurology, Department of Internal Medicine, Nippon Medical School, 1-1-5 Sendagi, Bunkyo-ku, Tokyo 113-8603, Japan. tomohiro@nms.ac.jp
|
pubmed:publicationType |
Journal Article
|